Newswise NYU School of Medicine announced today that Danny Reinberg, PhD, professor, Department of Biochemistry and Molecular Pharmacology, a Howard Hughes Medical Institute Investigator, and head of the Reinberg Lab at NYU School of Medicine, has been elected a member of the Institute of Medicine (IOM). Seventy new members and ten foreign associates were named during the IOMs 43nd annual meeting on October 21, 2013. Dr. Reinberg is NYU School of Medicines 10th faculty member inducted into the IOM. Dr. Reinbergs election into the IOM reflects the combination of intellect, effort, creativity, and excellence evident in his groundbreaking work and contributions to science and medicine, said Robert I. Grossman, MD, dean and CEO of NYU Langone Medical Center. We congratulate Dr. Reinberg on receiving this extraordinary honor. Dr. Reinberg is a leading expert in the fields of eukaryotic transcription and epigenetics. He and his collaborators have made fundamental discoveries uncovering the details of the intricate process of transcription during which information from DNA is transferred to RNA that directs protein production. In the field of epigenetics, the study of how genes are activated or deactivated by modifications to chromatin, changes in gene expression that can be passed on to future … Continue reading →

Newswise University of California, San Diego School of Medicine researchers Joseph G. Gleeson, MD, Howard Hughes Medical Institute investigator and professor of neurosciences and pediatrics, and Richard D. Kolodner, PhD, professor of medicine and Ludwig Cancer Research scientist, have been named new members of the Institute of Medicine (IOM), considered among the highest honors in the fields of health and medicine. Gleeson and Kolodner were among 70 new members and 10 foreign associates announces today at the IOMs annual meeting, bringing total IOM membership to 1,966 worldwide. Forty-six UC San Diego faculty members, current and emeritus, are IOM members. Joseph Gleeson Gleeson is principal investigator at the Center for Brain Development, a laboratory that seeks to understand the genetic basis of brain diseases such as mental retardation, epilepsy and autism using genetic tools. He is also director of the UC San Diego Neuroscience Core, co-director of the Biomedical Sciences Graduate Program and a member of the Institute for Genomic Medicine at UC San Diego. He is also a member of the Child Neurology Society, the Society for Neuroscience and the American Society for Human Genetics, and has served on the editorial boards of the Journal of Child Neurology, Human Molecular … Continue reading →

Orange County, California (PRWEB) October 21, 2013 The leading stem cell clinic on the West Coast, TeleHealth, is now offering stem cell injections for knees with both platelet rich plasma therapy and adult stem cells. The treatments have been showing amazing results for those with painful knee arthritis, cartilage defects and ligament injuries or tendonitis of the knee. For more information and scheduling, call (888) 828-4575. Tens of millions of Americans suffer from knee pain due to arthritis, cartilage defects or soft tissue injuries. Traditional treatments involve steroid injections, bracing or surgeries such as joint replacement. Regenerative medicine now offers a better option with stem cell injections that offer the potential for new cartilage growth and pain relief. The regenerative treatments offered at TeleHealth are performed by US Board Certified stem cell doctors with over 20 years experience. This includes bone marrow derived stem cell injections and platelet rich plasma therapy. These treatments place platelets, growth factors and stem cells into the area of damage and stimulate repair. They do not just mask pain like a steroid injection does. Recent published studies are showing the benefit or stem cells for knees, such as the one out of Hospital for Special … Continue reading →

With an operation to inject stem cells into the spinal cord of an ALS patient on Oct. 2, a team at the University of Michigan completed the first stage of its U.S. Food and Drug Administration trials to test a new therapy for the deadly neurological disease. It was the third operation to inject stem cells since the FDA gave approval last April for phase-two trials on 15 patients suffering from amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. The first operation was at Emory University Hospital in Atlanta, with the next two at UM. The recent operation, like the other two, involved injecting 200,000 stem cells at each of 10 sites in the cervical region of the spine. That area regulates breathing, and most ALS patients die from breathing difficulties. An independent panel of surgeons and neurological experts not affiliated with UM will assess the first three operations for safety. Eva Feldman, M.D., the principal investigator in the trials, which are funded in part by the National Institutes of Health and the ALS Association, expects the panel to give its approval in about a month to proceed to the next round of three operations, which will involve the … Continue reading →

Orange County, CA (PRWEB) October 21, 2013 The premier stem cell therapy clinic on the West Coast, Physician First Choice, is now offering IV stem cell treatment for numerous medical conditions. This includes stem cell treatment for Alzheimer's disease, Diabetes, Parkinson's, Liver Disease, Cardiac Disease, COPD and much more. The treatments are provided by US Board Certified Stem Cell Doctors and for more information call (888) 988-0515. Stem cell therapy has become available for numerous medical conditions and can dramatically improve the patient's baseline. Increasing amounts of research are showing the benefits of IV stem cell therapy for conditions such as diabetes and COPD. Prior to stem cell therapy, these conditions could be managed with traditional medications, but the disease itself could not be altered. With stem cell therapy, that possibility exists. The Board Certified stem cell doctors at Physician First Choice have over 20 combined years of experience working with patients for both stem cell injection treatment and IV therapy. The clinic treats patients at multiple Southern California locations along with an international location in Mexico. Patient treatment is performed by the same US Board Certified doctors before, during and after therapy to ensure continuity of care. The program … Continue reading →

OTTAWA, ONTARIO and TORONTO, ONTARIO--(Marketwired - Oct 21, 2013) - Stem cell and regenerative medicine experts from around the world will physically and virtually come together in Banff, Alberta, when Canada's premier stem cell research event - the Till & McCulloch Meetings (T&MM) - takes place October 23-25, 2013. "Canada and Europe chose the same dates to host their most significant regenerative medicine events and we're utilizing technology to bring the two conferences together," explains Drew Lyall, Executive Director of the Stem Cell Network. "While our European colleagues won't get to enjoy the beauty of Alberta, they will benefit from hearing some thrilling science, produced in Canada." A novel technology discovered in Dr. Peter Zandstra's lab, which has the potential to improve the viability and success of cord blood stem cell transplantation, will be featured during a live broadcast to the World Conference on Regenerative Medicine in Leipzig, Germany, on October 24 at 8:45 a.m. Dr. Zandstra (University of Toronto and CSO with the Centre for Commercialization of Regenerative Medicine) has received the 2013 Till & McCulloch Award for having published the year's most influential peer-reviewed article by a stem cell researcher in Canada. Other highlights include the following: October … Continue reading →